MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Total Liabilities Summary of MediPharm Labs Corp.

MediPharm Labs Corp.'s latest annual total liabilities in 2023 was 10.93 Million CAD , up 15.19% from previous year.
MediPharm Labs Corp.'s latest quarterly total liabilities in 2024 Q2 was 12.23 Million CAD , up 7.38% from previous quarter.
MediPharm Labs Corp. reported annual total liabilities of 9.49 Million CAD in 2022, up 2.98% from previous year.
MediPharm Labs Corp. reported annual total liabilities of 9.21 Million CAD in 2021, down -76.86% from previous year.
MediPharm Labs Corp. reported quarterly total liabilities of 12.23 Million CAD for 2024 Q2, up 7.38% from previous quarter.
MediPharm Labs Corp. reported quarterly total liabilities of 10.93 Million CAD for 2023 Q4, down -14.62% from previous quarter.

Annual Total Liabilities Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Total Liabilities of MediPharm Labs Corp. (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	10.93 Million CAD	15.19%
2022	9.49 Million CAD	2.98%
2021	9.21 Million CAD	-76.86%
2020	39.81 Million CAD	5.89%
2019	37.6 Million CAD	152.61%
2018	14.88 Million CAD	489.78%
2017	2.52 Million CAD	5301.7%
2016	46.72 Thousand CAD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	11.39 Million CAD	4.19%
2024 Q2	12.23 Million CAD	7.38%
2023 Q4	10.93 Million CAD	-14.62%
2023 FY	10.93 Million CAD	15.19%
2023 Q2	14.51 Million CAD	73.03%
2023 Q1	8.38 Million CAD	-11.62%
2023 Q3	12.8 Million CAD	-11.77%
2022 Q2	10.67 Million CAD	26.69%
2022 Q4	9.49 Million CAD	-11.77%
2022 FY	9.49 Million CAD	2.98%
2022 Q1	8.42 Million CAD	-8.57%
2022 Q3	10.75 Million CAD	0.77%
2021 Q1	18.57 Million CAD	-53.36%
2021 FY	9.21 Million CAD	-76.86%
2021 Q4	9.21 Million CAD	-40.87%
2021 Q3	15.58 Million CAD	-16.48%
2021 Q2	18.65 Million CAD	0.46%
2020 FY	39.81 Million CAD	5.89%
2020 Q1	25.68 Million CAD	-31.7%
2020 Q2	61.54 Million CAD	139.63%
2020 Q3	45.96 Million CAD	-25.31%
2020 Q4	39.81 Million CAD	-13.37%
2019 Q2	53.2 Million CAD	48.82%
2019 FY	37.6 Million CAD	152.61%
2019 Q4	37.6 Million CAD	-30.42%
2019 Q3	54.04 Million CAD	1.59%
2019 Q1	35.74 Million CAD	140.15%
2018 Q3	33.94 Thousand CAD	169.88%
2018 FY	14.88 Million CAD	489.78%
2018 Q1	13.11 Thousand CAD	116.97%
2018 Q2	12.57 Thousand CAD	-4.1%
2018 Q4	14.88 Million CAD	43753.29%
2017 FY	2.52 Million CAD	5301.7%
2017 Q4	6045.00 CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q1	- CAD	0.0%
2016 FY	46.72 Thousand CAD	0.0%

Peer Total Liabilities Comparison of MediPharm Labs Corp.

Name	Total Liabilities	Total Liabilities Difference
Aurora Cannabis Inc.	236.8 Million CAD	95.384%
Avicanna Inc.	13.99 Million CAD	21.909%
Avant Brands Inc.	33.22 Million CAD	67.096%
Cardiol Therapeutics Inc.	8.45 Million CAD	-29.312%
Crescita Therapeutics Inc.	5.77 Million CAD	-89.266%
Knight Therapeutics Inc.	198.62 Million CAD	94.496%
OrganiGram Holdings Inc.	26.83 Million CAD	59.258%
Canopy Growth Corporation	799.82 Million CAD	98.633%
Willow Biosciences Inc.	3.23 Million CAD	-237.72%
Auxly Cannabis Group Inc.	210.85 Million CAD	94.815%